Refine your search

Report of the European Society of Cardiology Cardiovascular Round Table regulatory workshop update of the evaluation of new agents for the treatment of acute coronary syndrome: Executive summary

Conflict of interest Hector Bueno: research grants from AstraZeneca and advisory/speaker fees from Abbott, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Eli Lilly, Ferrer, Menarini, Novartis, Pfizer, ...

European Heart Journal: Acute Cardiovascular Care, Executive Summary, HÃ©ctor Bueno, Pieter de Graeff, Isabelle Richard-Lordereau, Joseph Emmerich, Keith AA Fox, Carola P Friedman, Christophe ...

Date : 29/06/2016

Report of the European Society of Cardiology Cardiovascular Round Table regulatory workshop update of the evaluation of new agents for the treatment of acute coronary syndrome: Executive summary

Conflict of interest Hector Bueno: research grants from AstraZeneca and advisory/speaker fees from Abbott, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Eli Lilly, Ferrer, Menarini, Novartis, Pfizer, ...

European Heart Journal: Acute Cardiovascular Care, Executive Summary, HÃ©ctor Bueno, Pieter de Graeff, Isabelle Richard-Lordereau, Joseph Emmerich, Keith AA Fox, Carola P Friedman, Christophe ...

Date : 29/06/2016

Report of the European Society of Cardiology Cardiovascular Round Table regulatory workshop update of the evaluation of new agents for the treatment of acute coronary syndrome: Executive summary

Conflict of interest Hector Bueno: research grants from AstraZeneca and advisory/speaker fees from Abbott, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Eli Lilly, Ferrer, Menarini, Novartis, Pfizer, ...

European Heart Journal: Acute Cardiovascular Care, Executive Summary, HÃ©ctor Bueno, Pieter de Graeff, Isabelle Richard-Lordereau, Joseph Emmerich, Keith AA Fox, Carola P Friedman, Christophe ...

Date : 29/06/2016

Report of the European Society of Cardiology Cardiovascular Round Table regulatory workshop update of the evaluation of new agents for the treatment of acute coronary syndrome: Executive summary

Conflict of interest Hector Bueno: research grants from AstraZeneca and advisory/speaker fees from Abbott, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Eli Lilly, Ferrer, Menarini, Novartis, Pfizer, ...

European Heart Journal: Acute Cardiovascular Care, Executive Summary, HÃ©ctor Bueno, Pieter de Graeff, Isabelle Richard-Lordereau, Joseph Emmerich, Keith AA Fox, Carola P Friedman, Christophe ...

Date : 29/06/2016

Report of the European Society of Cardiology Cardiovascular Round Table regulatory workshop update of the evaluation of new agents for the treatment of acute coronary syndrome: Executive summary

Conflict of interest Hector Bueno: research grants from AstraZeneca and advisory/speaker fees from Abbott, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Eli Lilly, Ferrer, Menarini, Novartis, Pfizer, ...

European Heart Journal: Acute Cardiovascular Care, Executive Summary, HÃ©ctor Bueno, Pieter de Graeff, Isabelle Richard-Lordereau, Joseph Emmerich, Keith AA Fox, Carola P Friedman, Christophe ...

Date : 29/06/2016

Report of the European Society of Cardiology Cardiovascular Round Table regulatory workshop update of the evaluation of new agents for the treatment of acute coronary syndrome: Executive summary

Conflict of interest Hector Bueno: research grants from AstraZeneca and advisory/speaker fees from Abbott, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Eli Lilly, Ferrer, Menarini, Novartis, Pfizer, ...

European Heart Journal: Acute Cardiovascular Care, Executive Summary, HÃ©ctor Bueno, Pieter de Graeff, Isabelle Richard-Lordereau, Joseph Emmerich, Keith AA Fox, Carola P Friedman, Christophe ...

Date : 29/06/2016

Report of the European Society of Cardiology Cardiovascular Round Table regulatory workshop update of the evaluation of new agents for the treatment of acute coronary syndrome: Executive summary

Conflict of interest Hector Bueno: research grants from AstraZeneca and advisory/speaker fees from Abbott, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Eli Lilly, Ferrer, Menarini, Novartis, Pfizer, ...

European Heart Journal: Acute Cardiovascular Care, Executive Summary, HÃ©ctor Bueno, Pieter de Graeff, Isabelle Richard-Lordereau, Joseph Emmerich, Keith AA Fox, Carola P Friedman, Christophe ...

Date : 29/06/2016

Report of the European Society of Cardiology Cardiovascular Round Table regulatory workshop update of the evaluation of new agents for the treatment of acute coronary syndrome: Executive summary

Conflict of interest Hector Bueno: research grants from AstraZeneca and advisory/speaker fees from Abbott, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Eli Lilly, Ferrer, Menarini, Novartis, Pfizer, ...

European Heart Journal: Acute Cardiovascular Care, Executive Summary, HÃ©ctor Bueno, Pieter de Graeff, Isabelle Richard-Lordereau, Joseph Emmerich, Keith AA Fox, Carola P Friedman, Christophe ...

Date : 29/06/2016

Report of the European Society of Cardiology Cardiovascular Round Table regulatory workshop update of the evaluation of new agents for the treatment of acute coronary syndrome: Executive summary

Conflict of interest Hector Bueno: research grants from AstraZeneca and advisory/speaker fees from Abbott, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Eli Lilly, Ferrer, Menarini, Novartis, Pfizer, ...

European Heart Journal: Acute Cardiovascular Care, Executive Summary, HÃ©ctor Bueno, Pieter de Graeff, Isabelle Richard-Lordereau, Joseph Emmerich, Keith AA Fox, Carola P Friedman, Christophe ...

Date : 29/06/2016

Report of the European Society of Cardiology Cardiovascular Round Table regulatory workshop update of the evaluation of new agents for the treatment of acute coronary syndrome: Executive summary

Conflict of interest Hector Bueno: research grants from AstraZeneca and advisory/speaker fees from Abbott, AstraZeneca, Bayer, BMS, Daiichi Sankyo, Eli Lilly, Ferrer, Menarini, Novartis, Pfizer, ...

European Heart Journal: Acute Cardiovascular Care, Executive Summary, HÃ©ctor Bueno, Pieter de Graeff, Isabelle Richard-Lordereau, Joseph Emmerich, Keith AA Fox, Carola P Friedman, Christophe ...

Date : 29/06/2016